Review: could Hydrochlorothiazide cause Hyperparathyroidism secondary?
Summary: Hyperparathyroidism secondary is reported only by a few people who take Hydrochlorothiazide.
We study 60,063 people who have side effects while taking Hydrochlorothiazide from FDA and social media. Among them, 4 have Hyperparathyroidism secondary. Find out below who they are, when they have Hyperparathyroidism secondary and more.
You are not alone: join a support group for people who take Hydrochlorothiazide and have Hyperparathyroidism secondary >>>
Hydrochlorothiazide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. (latest outcomes from 62,015 Hydrochlorothiazide users)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary) has been reported by people with osteoporosis, high blood pressure, renal failure chronic, dialysis, osteopenia. (latest reports from 3,552 Hyperparathyroidism secondary patients)
On Mar, 22, 2015: 60,063 people reported to have side effects when taking Hydrochlorothiazide. Among them, 4 people (0.01%) have Hyperparathyroidism Secondary.
Time on Hydrochlorothiazide when people have Hyperparathyroidism secondary * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Hyperparathyroidism secondary||100.00%||0.00%||0.00%||0.00%||0.00%||0.00%||0.00% |
Gender of people who have Hyperparathyroidism secondary when taking Hydrochlorothiazide * :
|Hyperparathyroidism secondary||75.00%||25.00% |
Age of people who have Hyperparathyroidism secondary when taking Hydrochlorothiazide * :
|Hyperparathyroidism secondary||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||100.00% |
Severity of Hyperparathyroidism secondary when taking Hydrochlorothiazide ** :
How people recovered from Hyperparathyroidism secondary ** :
Top conditions involved for these people * :
- Renal failure chronic (2 people, 50.00%)
- Arthritis (1 people, 25.00%)
- Immunodeficiency (1 people, 25.00%)
- Hyperparathyroidism secondary (1 people, 25.00%)
Top co-used drugs for these people * :
- Aspirin (4 people, 100.00%)
- Norvasc (3 people, 75.00%)
- Vitamin d (3 people, 75.00%)
- Oxycontin (2 people, 50.00%)
- Prevacid (2 people, 50.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Hyperparathyroidism Secondary while taking Hydrochlorothiazide?
You are not alone! Join a support group on :
- support group for people who take Hydrochlorothiazide and have Hyperparathyroidism Secondary
- support group for people who take Hydrochlorothiazide
- support group for people who have Hyperparathyroidism Secondary
Drugs in real world that are associated with:
Could your condition cause:
Recent Hydrochlorothiazide related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.